Optical spectroscopy devices are being developed and tested for the screening and diagnosis of oral precancer and cancer lesions. This study reports a device that uses white light for detection of suspicious lesions a...Optical spectroscopy devices are being developed and tested for the screening and diagnosis of oral precancer and cancer lesions. This study reports a device that uses white light for detection of suspicious lesions and green–amber light at 545 nm that detect tissue vascularity on patients with several suspicious oral lesions. The clinical grading of vascularity was compared to the histological grading of the biopsied lesions using specific biomarkers. Such a device, in the hands of dentists and other health professionals, could greatly increase the number of oral cancerous lesions detected in early phase. The purpose of this study is to correlate the clinical grading of tissue vascularity in several oral suspicious lesions using the IdentafiH system with the histological grading of the biopsied lesions using specific vascular markers. Twenty-one patients with various oral lesions were enrolled in the study. The lesions were visualized using IdentafiH device with white light illumination, followed by visualization of tissue autofluorescence and tissue reflectance. Tissue biopsied was obtained from the all lesions and both histopathological and immunohistochemical studies using a vascular endothelial biomarker（CD34） were performed on these tissue samples. The clinical vascular grading using the green–amber light at 545 nm and the expression pattern and intensity of staining for CD34 in the different biopsies varied depending on lesions, grading ranged from 1 to3. The increase in vascularity was observed in abnormal tissues when compared to normal mucosa, but this increase was not limited to carcinoma only as hyperkeratosis and other oral diseases, such as lichen planus, also showed increase in vascularity. Optical spectroscopy is a promising technology for the detection of oral mucosal abnormalities; however, further investigations with a larger population group is required to evaluate the usefulness of these devices in differentiating benign lesions from potentially malignant lesions.展开更多
目的:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针,并研究其与NK-92MI细胞的结合能力、毒性、细胞体外MRI成像能力、促进NK-92MI细胞对MDA-MB-231三阴性乳腺癌细胞的杀伤能力。方法:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monali...目的:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针,并研究其与NK-92MI细胞的结合能力、毒性、细胞体外MRI成像能力、促进NK-92MI细胞对MDA-MB-231三阴性乳腺癌细胞的杀伤能力。方法:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针,利用透射电子显微镜(Transmission Electron Microscope,TEM)进行表征,并使用ImageJ对其粒径进行统计;通过流式细胞术分析纳米材料和NK-92MI细胞的结合能力;应用MRI对纳米探针标记的NK-92MI细胞体外成像并分析其T1加权(T1WI)的信号改变。利用蛋白印迹(Western blot)检测经过与NK-92MI细胞共培养后三阴性乳腺癌MDA-MB-231细胞凋亡相关蛋白的表达以及Elisa法检测培养体系内的IFN-γ的表达量。结果:制备的纳米探针颗粒粒径分布均匀,形态近似球形。其与NK-92MI细胞结合的量以及T1信号随着纳米探针浓度增加而逐渐增加。使用Monalizumab和IPH4301两种抗体修饰的纳米探针增强了NK-92MI细胞释放IFN-γ并促进MDA-MB-231乳腺癌细胞的凋亡。结论:PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针在结合NK-92MI细胞后,可以在3.0T磁共振下进行体外成像,并增强了NK-92MI细胞对MDA-MB-231细胞的杀伤能力。展开更多
目的:探讨Fe3O4-PEG-CD56/Avastin@Ce6靶向探针与NK92细胞的结合能力并进行细胞体外MRI成像。方法:制备Fe3O4-PEG-CD56/Avastin@Ce6纳米探针,对合成的材料进行表征。应用凋亡试剂盒测定不同浓度的材料对NK92的细胞毒性,通过流式细胞术...目的:探讨Fe3O4-PEG-CD56/Avastin@Ce6靶向探针与NK92细胞的结合能力并进行细胞体外MRI成像。方法:制备Fe3O4-PEG-CD56/Avastin@Ce6纳米探针,对合成的材料进行表征。应用凋亡试剂盒测定不同浓度的材料对NK92的细胞毒性,通过流式细胞术分析纳米材料与NK92细胞的结合能力和应用MRI对细胞进行体外成像并分析其T2信号强度的改变。结果:合成的纳米探针具有较好的生物相容性,且对NK92细胞的影响较小,不同浓度下细胞凋亡水平基本一致,与NK92细胞结合的材料随浓度的增加而逐渐增加。MRI检查提示不同浓度探针孵育的NK92细胞T2加权像(T2WI)的信号均降低。结论:Fe3O4-PEG-CD56/Avastin@Ce6探针对NK92细胞具有靶向性,3.0 T MR扫描仪可对其进行体外监测。展开更多
文摘Optical spectroscopy devices are being developed and tested for the screening and diagnosis of oral precancer and cancer lesions. This study reports a device that uses white light for detection of suspicious lesions and green–amber light at 545 nm that detect tissue vascularity on patients with several suspicious oral lesions. The clinical grading of vascularity was compared to the histological grading of the biopsied lesions using specific biomarkers. Such a device, in the hands of dentists and other health professionals, could greatly increase the number of oral cancerous lesions detected in early phase. The purpose of this study is to correlate the clinical grading of tissue vascularity in several oral suspicious lesions using the IdentafiH system with the histological grading of the biopsied lesions using specific vascular markers. Twenty-one patients with various oral lesions were enrolled in the study. The lesions were visualized using IdentafiH device with white light illumination, followed by visualization of tissue autofluorescence and tissue reflectance. Tissue biopsied was obtained from the all lesions and both histopathological and immunohistochemical studies using a vascular endothelial biomarker（CD34） were performed on these tissue samples. The clinical vascular grading using the green–amber light at 545 nm and the expression pattern and intensity of staining for CD34 in the different biopsies varied depending on lesions, grading ranged from 1 to3. The increase in vascularity was observed in abnormal tissues when compared to normal mucosa, but this increase was not limited to carcinoma only as hyperkeratosis and other oral diseases, such as lichen planus, also showed increase in vascularity. Optical spectroscopy is a promising technology for the detection of oral mucosal abnormalities; however, further investigations with a larger population group is required to evaluate the usefulness of these devices in differentiating benign lesions from potentially malignant lesions.
文摘目的:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针,并研究其与NK-92MI细胞的结合能力、毒性、细胞体外MRI成像能力、促进NK-92MI细胞对MDA-MB-231三阴性乳腺癌细胞的杀伤能力。方法:制备PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针,利用透射电子显微镜(Transmission Electron Microscope,TEM)进行表征,并使用ImageJ对其粒径进行统计;通过流式细胞术分析纳米材料和NK-92MI细胞的结合能力;应用MRI对纳米探针标记的NK-92MI细胞体外成像并分析其T1加权(T1WI)的信号改变。利用蛋白印迹(Western blot)检测经过与NK-92MI细胞共培养后三阴性乳腺癌MDA-MB-231细胞凋亡相关蛋白的表达以及Elisa法检测培养体系内的IFN-γ的表达量。结果:制备的纳米探针颗粒粒径分布均匀,形态近似球形。其与NK-92MI细胞结合的量以及T1信号随着纳米探针浓度增加而逐渐增加。使用Monalizumab和IPH4301两种抗体修饰的纳米探针增强了NK-92MI细胞释放IFN-γ并促进MDA-MB-231乳腺癌细胞的凋亡。结论:PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针在结合NK-92MI细胞后,可以在3.0T磁共振下进行体外成像,并增强了NK-92MI细胞对MDA-MB-231细胞的杀伤能力。
文摘目的:探讨Fe3O4-PEG-CD56/Avastin@Ce6靶向探针与NK92细胞的结合能力并进行细胞体外MRI成像。方法:制备Fe3O4-PEG-CD56/Avastin@Ce6纳米探针,对合成的材料进行表征。应用凋亡试剂盒测定不同浓度的材料对NK92的细胞毒性,通过流式细胞术分析纳米材料与NK92细胞的结合能力和应用MRI对细胞进行体外成像并分析其T2信号强度的改变。结果:合成的纳米探针具有较好的生物相容性,且对NK92细胞的影响较小,不同浓度下细胞凋亡水平基本一致,与NK92细胞结合的材料随浓度的增加而逐渐增加。MRI检查提示不同浓度探针孵育的NK92细胞T2加权像(T2WI)的信号均降低。结论:Fe3O4-PEG-CD56/Avastin@Ce6探针对NK92细胞具有靶向性,3.0 T MR扫描仪可对其进行体外监测。
